Apellis Pharmaceuticals, Inc.
APLS
$18.20
$0.040.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.08% | 9.69% | 10.34% | -6.19% | -23.63% |
| Total Receivables | -4.31% | -8.06% | 13.41% | 21.31% | 20.06% |
| Inventory | -36.21% | -20.27% | -7.38% | 7.66% | 41.11% |
| Prepaid Expenses | 5.93% | -23.76% | -29.54% | 94.45% | -32.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.42% | -12.83% | -33.53% | -8.75% | -7.87% |
| Total Current Assets | -5.39% | -3.03% | 5.98% | 5.88% | -3.82% |
|
|
|||||
| Total Current Assets | -5.39% | -3.03% | 5.98% | 5.88% | -3.82% |
| Net Property, Plant & Equipment | -6.87% | 1.40% | 5.04% | -9.01% | 4.02% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.13% | 95.19% | 1,754.61% | 0.31% | 11.40% |
| Total Assets | -1.86% | -0.29% | 8.72% | 5.48% | -3.60% |
|
|
|||||
| Total Accounts Payable | -9.73% | 11.65% | 42.86% | -28.60% | 106.22% |
| Total Accrued Expenses | 0.25% | 13.89% | 21.09% | -20.66% | 9.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.57% | 9.30% | -0.69% | -2.86% | 12.23% |
| Total Finance Division Other Current Liabilities | -- | 0.00% | -97.65% | 6.62% | 69.98% |
| Total Other Current Liabilities | -- | 0.00% | -97.65% | 6.62% | 69.98% |
| Total Current Liabilities | -3.01% | 13.06% | -21.42% | -13.05% | 33.38% |
|
|
|||||
| Total Current Liabilities | -3.01% | 13.06% | -21.42% | -13.05% | 33.38% |
| Long-Term Debt | 0.13% | -1.09% | 391.05% | 0.08% | 0.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.60% | 2.94% | 13.46% | -14.70% | 5.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -18.89% | 265.25% | -98.91% | 2.05% | -18.33% |
| Total Liabilities | -1.24% | 3.84% | 13.25% | -4.87% | 1.41% |
|
|
|||||
| Common Stock & APIC | 0.86% | 0.94% | 1.11% | 4.56% | 1.79% |
| Retained Earnings | -1.21% | -1.95% | -1.30% | -2.34% | -3.22% |
| Treasury Stock & Other | -5.35% | 6.60% | 4.62% | 0.48% | -232.58% |
| Total Common Equity | -3.62% | -10.29% | -0.88% | 37.09% | -16.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.62% | -10.29% | -0.88% | 37.09% | -16.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.62% | -10.29% | -0.88% | 37.09% | -16.25% |
|
|
|||||